Prescribing Restrictions For New Drug Approvals Getting Closer FDA Scrutiny
Executive Summary
FDA believes it has existing authority from a provision in the 1997 Modernization Act to make more use of strict prescribing limitations on new drug approvals.
You may also be interested in...
FDA Lotronex Letter Cites Desire To Work With Glaxo To Maintain Therapy
FDA is willing to continue working with Glaxo Wellcome on a risk management program for Lotronex, the agency said in a Dec. 18 letter to consumers.
FDA Lotronex Letter Cites Desire To Work With Glaxo To Maintain Therapy
FDA is willing to continue working with Glaxo Wellcome on a risk management program for Lotronex, the agency said in a Dec. 18 letter to consumers.
Henney Calls FDA Commissioner "Best Job"; Low-Key Bid To Stay Is Long Shot
FDA Commissioner Henney is sending clear public signals that she would be interested in staying with the agency into the Bush Administration.